BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36651797)

  • 1. High therapeutic efficacy of 5-Fluorouracil-loaded exosomes against colon cancer cells.
    Shekh R; Ahmad A; Tiwari RK; Saeed M; Shukla R; Al-Thubiani WS; Ansari IA; Ashfaque M; Bajpai P
    Chem Biol Drug Des; 2023 Apr; 101(4):962-976. PubMed ID: 36651797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer.
    Liang G; Zhu Y; Ali DJ; Tian T; Xu H; Si K; Sun B; Chen B; Xiao Z
    J Nanobiotechnology; 2020 Jan; 18(1):10. PubMed ID: 31918721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro additive antitumor effects of dimethoxycurcumin and 5-fluorouracil in colon cancer cells.
    Zhao H; Liu Q; Wang S; Dai F; Cheng X; Cheng X; Chen W; Zhang M; Chen D
    Cancer Med; 2017 Jul; 6(7):1698-1706. PubMed ID: 28573788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosome-Mediated Transfer of circ_0000338 Enhances 5-Fluorouracil Resistance in Colorectal Cancer through Regulating MicroRNA 217 (miR-217) and miR-485-3p.
    Zhao K; Cheng X; Ye Z; Li Y; Peng W; Wu Y; Xing C
    Mol Cell Biol; 2021 Apr; 41(5):. PubMed ID: 33722958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cell-derived exosome-entrapped fluorouracil can enhance its anti-colon cancer effect.
    Xu M; Chen Q; Li J; Peng L; Ding L
    J BUON; 2020; 25(3):1413-1422. PubMed ID: 32862584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrinβ6-targeted immunoliposomes mediate tumor-specific drug delivery and enhance therapeutic efficacy in colon carcinoma.
    Liang B; Shahbaz M; Wang Y; Gao H; Fang R; Niu Z; Liu S; Wang B; Sun Q; Niu W; Liu E; Wang J; Niu J
    Clin Cancer Res; 2015 Mar; 21(5):1183-95. PubMed ID: 25549721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of the histone deacetylase inhibitor depsipeptide and 5-fluorouracil upregulates major histocompatibility complex class II and p21 genes and activates caspase-3/7 in human colon cancer HCT-116 cells.
    Okada K; Hakata S; Terashima J; Gamou T; Habano W; Ozawa S
    Oncol Rep; 2016 Oct; 36(4):1875-85. PubMed ID: 27509880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frondoside A Enhances the Anti-Cancer Effects of Oxaliplatin and 5-Fluorouracil on Colon Cancer Cells.
    Attoub S; Arafat K; Khalaf T; Sulaiman S; Iratni R
    Nutrients; 2018 May; 10(5):. PubMed ID: 29724012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VMP1 promotes exosome secretion and enhances 5-FU resistance in colon cancer cells.
    Wei X; Yang Z; Chen G; Huang J
    Tissue Cell; 2022 Aug; 77():101851. PubMed ID: 35696974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemcitabine loaded autologous exosomes for effective and safe chemotherapy of pancreatic cancer.
    Li YJ; Wu JY; Wang JM; Hu XB; Cai JX; Xiang DX
    Acta Biomater; 2020 Jan; 101():519-530. PubMed ID: 31629893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,3-Bis(2-chloroethyl)-1-nitrosourea enhances the inhibitory effect of resveratrol on 5-fluorouracil sensitive/resistant colon cancer cells.
    Das D; Preet R; Mohapatra P; Satapathy SR; Kundu CN
    World J Gastroenterol; 2013 Nov; 19(42):7374-88. PubMed ID: 24259968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronic acid-tagged silica nanoparticles in colon cancer therapy: therapeutic efficacy evaluation.
    Liu K; Wang ZQ; Wang SJ; Liu P; Qin YH; Ma Y; Li XC; Huo ZJ
    Int J Nanomedicine; 2015; 10():6445-54. PubMed ID: 26491300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin Reverses 5-Fluorouracil Resistance by Promoting Human Colon Cancer HCT-8/5-FU Cell Apoptosis and Down-regulating Heat Shock Protein 27 and P-Glycoprotein.
    He WT; Zhu YH; Zhang T; Abulimiti P; Zeng FY; Zhang LP; Luo LJ; Xie XM; Zhang HL
    Chin J Integr Med; 2019 Jun; 25(6):416-424. PubMed ID: 30484020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cisplatin, 5-fluorouracil, and radiation on cell cycle regulation and apoptosis in the hypopharyngeal carcinoma cell line.
    Lee BJ; Chon KM; Kim YS; An WG; Roh HJ; Goh EK; Wang SG
    Chemotherapy; 2005 May; 51(2-3):103-10. PubMed ID: 15886465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Fluorouracil-loaded poly(ε-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer.
    Ortiz R; Prados J; Melguizo C; Arias JL; Ruiz MA; Alvarez PJ; Caba O; Luque R; Segura A; Aránega A
    Int J Nanomedicine; 2012; 7():95-107. PubMed ID: 22275826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Fas expression by RNAi modulates 5-fluorouracil-induced apoptosis in HCT116 cells expressing wild-type p53.
    Borralho PM; Moreira da Silva IB; Aranha MM; Albuquerque C; Nobre Leitão C; Steer CJ; Rodrigues CM
    Biochim Biophys Acta; 2007 Jan; 1772(1):40-7. PubMed ID: 17056233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chloramidine/Bisindolylmaleimide-I-Mediated Inhibition of Exosome and Microvesicle Release and Enhanced Efficacy of Cancer Chemotherapy.
    Kosgodage US; Trindade RP; Thompson PR; Inal JM; Lange S
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28486412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective inhibition of colon cancer cell growth with MgAl-layered double hydroxide (LDH) loaded 5-FU and PI3K/mTOR dual inhibitor BEZ-235 through apoptotic pathways.
    Chen J; Shao R; Li L; Xu ZP; Gu W
    Int J Nanomedicine; 2014; 9():3403-11. PubMed ID: 25075187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced Susceptibility to 5-Fluorouracil in Human Colon Cancer Cells by Silencing of GRP78.
    Yun S; Han YS; Lee JH; Kim S; Lee SH
    Anticancer Res; 2017 Jun; 37(6):2975-2984. PubMed ID: 28551635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis, cell cycle progression and gene expression in TP53-depleted HCT116 colon cancer cells in response to short-term 5-fluorouracil treatment.
    Adamsen BL; Kravik KL; Clausen OP; De Angelis PM
    Int J Oncol; 2007 Dec; 31(6):1491-500. PubMed ID: 17982676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.